These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 714030)

  • 1. Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver.
    Glowinski IB; Radtke HE; Weber WW
    Mol Pharmacol; 1978 Sep; 14(5):940-9. PubMed ID: 714030
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes.
    Hein DW; Doll MA; Ferguson RJ
    Proc West Pharmacol Soc; 1995; 38():59-62. PubMed ID: 7480023
    [No Abstract]   [Full Text] [Related]  

  • 3. Histological localization of messenger RNAs for rat acetyltransferases that acetylate serotonin and genotoxic arylamines.
    Debiec-Rychter M; Land SJ; King CM
    Cancer Res; 1996 Apr; 56(7):1517-25. PubMed ID: 8603396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase.
    Hein DW; Weber WW
    Drug Metab Dispos; 1982; 10(3):225-9. PubMed ID: 6125354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetylation of drugs. A genetically controlled reciprocal relationship between drug N-acetylating enzymes of rabbit liver and peripheral blood cells.
    Szabadi RR; McQueen CA; Drummond GS; Weber WW
    Drug Metab Dispos; 1978; 6(1):16-20. PubMed ID: 23269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities.
    Lower GM; Bryan GT
    Biochem Pharmacol; 1973 Jul; 22(13):1581-8. PubMed ID: 4729805
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular basis of hereditary acetylation polymorphisms.
    Weber WW
    Drug Metab Dispos; 1986; 14(4):377-81. PubMed ID: 2873981
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterification.
    Kato R; Yamazoe Y
    Drug Metab Rev; 1994; 26(1-2):413-29. PubMed ID: 8082577
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
    Chou HC; Lang NP; Kadlubar FF
    Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylation of drugs: search for INH acetylation polymorphism in baboons.
    Radtke HE; Brenner W; Weber WW
    Drug Metab Dispos; 1979; 7(3):194-5. PubMed ID: 38093
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
    Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
    Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localization of N-acetyltransferases in sinusoidal liver cells. Effect of zymosan on the acetylation of sulfamethazine and isoniazid in the rat and in isolated perfused liver].
    Notter D; Roland E
    C R Seances Soc Biol Fil; 1978; 172(3):531-3. PubMed ID: 153185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation pharmacogenetics: experimental models for human toxicity.
    Weber WW
    Fed Proc; 1984 May; 43(8):2332-7. PubMed ID: 6714442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation, metabolic activation by N, O-acyltransfer, and hydrolysis of N-acyl-N-arylamine derivatives.
    King CM; Weber WW
    Natl Cancer Inst Monogr; 1981 Dec; (58):117-22. PubMed ID: 7341969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenic aromatic amine metabolism and DNA adduct detection in humans.
    Kadlubar FF
    Princess Takamatsu Symp; 1990; 21():329-38. PubMed ID: 2134686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver.
    Hein DW; Hirata M; Glowinski IB; Weber WW
    J Pharmacol Exp Ther; 1982 Jan; 220(1):1-7. PubMed ID: 7053406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates.
    Kato R; Yamazoe Y
    Jpn J Cancer Res; 1987 Apr; 78(4):297-311. PubMed ID: 3108208
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetyltransferase and sulfotransferase which activate mutagens and carcinogens through O-esterification mechanisms.
    Yamazoe Y; Abu-Zeid M; Gong DW; Ozawa S; Nagata K; Kato R
    Princess Takamatsu Symp; 1990; 21():109-17. PubMed ID: 2134670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.